Not currently recruiting at UCSF
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis
Summary
- Eligibility
- for people ages 4 years and up (full criteria)
- Location
- at Oakland 5378538, California 5332921 and other locations
- Dates
- study startedstudy ends around
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Azafaros A.G.
- ID
- NCT07054515
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 147 study participants
- Last Updated